封面
市场调查报告书
商品编码
1878175

全球骨骼与关节健康补充品市场-2025-2030年预测

Global Bone And Joint Health Supplements Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球骨骼和关节健康补充剂市场预计将从 2025 年的 120.66 亿美元增长到 2030 年的 171.94 亿美元,复合年增长率为 7.34%。

骨骼为身体器官提供结构支撑和保护,关节则使身体能够移动。维持骨骼和关节健康对整体健康至关重要,而钙是维持骨骼完整性的关键营养素。骨骼和关节保健品含有必需的维生素和矿物质,有助于维持骨骼密度、改善关节活动范围、缓解关节疼痛,并延缓骨关节炎等疾病的进展。这些产品为支持骨骼系统提供了一种便捷的方式,尤其能够解决因老龄化导致的骨骼密度自然流失而引起的营养缺乏问题,而骨密度流失最初通常表现为关节不适。由于人口结构变化和消费者健康意识的提高,这类保健品市场需求显着增长。

主要市场驱动因素

骨骼和关节保健品市场的扩张主要受全球人口老化趋势以及消费者对营养缺乏症认识提高的推动。

全球人口老化是推动该市场需求的最重要因素。老年人族群尤其容易患上损害骨骼和关节健康的疾病,例如骨质疏鬆症和类风湿性关节炎。自然老龄化过程会导致骨骼密度下降和关节软骨磨损,增加骨折、疼痛和活动受限的发生率。老年人群体寻求保持积极独立生活方式的解决方案,这为保健品生产商创造了一个庞大且不断增长的目标市场。对关节舒适度和活动能力的追求是强大的消费动力,促使消费者愿意为能够针对这些与老龄化的健康问题提供特定支援的产品支付更高的价格。

除了人口结构压力外,健康意识的广泛提升也推动了市场成长。消费者越来越了解营养与长期健康之间的联繫,尤其是某些微量营养素缺乏在骨骼和关节疾病发展中所扮演的角色。这种意识促使人们采取积极主动的健康管理方式,越来越多的人开始服用膳食补充剂作为预防措施。许多地区中产阶级的壮大和可支配收入的增加,使得人们能够更多地用于健康促进和预防性保健产品。此外,年轻人积极参与体育运动和健身活动,服用这些补充剂来支持关节功能和缓解运动压力,进一步推动了这一趋势,并将消费群体扩展到老年人以外的人群。

区域市场展望

预计北美将占据全球骨骼和关节保健品市场的主要份额。该地区的领先地位源于多方面因素的共同作用:庞大且不断增长的老龄人口、关节炎等关节疾病的高发生率,以及成熟的健康养生消费文化。人们对预防性医疗保健重要性的深刻认识以及长期服用膳食补充剂的习惯,共同促成了成熟且接受度高的市场的形成。高发生率的关节炎诊断率和人群中普遍存在的微量营养素缺乏症,持续推动对骨骼和关节健康解决方案的需求。

然而,预计亚太地区在预测期内将实现最快成长。这项加速成长受多种因素驱动,包括普遍存在的营养不良、人们健康意识的迅速提高,以及骨质疏鬆症和维生素D缺乏症等疾病的日益普遍。该地区的经济发展是主要驱动力,可支配收入的增加使消费者能够更多地购买高端保健产品,包括专业营养补充剂。庞大的人口基数、不断增长的都市化以及现代健康理念的普及,为亚太地区带来了巨大的成长潜力。亚太地区营养补充品公司的策略性企业发展和行销倡议,正进一步加速其市场渗透和扩张。

本报告的主要优势:

  • 深入分析:提供对主要和新兴地区的深入市场洞察,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局:了解全球主要参与者的策略倡议,并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势:探索市场驱动因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议:利用洞察力,做出策略决策,在动态环境中发展新的业务流和收入来源。
  • 受众广泛:适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业,且经济实惠。

您打算如何使用这份报告?

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围:

  • 2022年至2024年的历史数据和2025年至2030年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入成长和预测评估,包括国家/地区
  • 公司概况(策略、产品、财务资讯、关键发展等)

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球骨骼和关节健康补充品市场(按类型划分)

  • 介绍
  • 葡萄糖胺
  • 软骨素
  • Omega-3脂肪酸
  • 维生素和矿物质补充剂
  • 其他的

6. 全球骨骼和关节健康补充品市场(按配方划分)

  • 介绍
  • 胶囊和片剂
  • 粉末
  • 液体和软胶囊
  • 其他的

7. 全球骨骼和关节健康补充品市场(按分销管道划分)

  • 介绍
  • 在线的
  • 离线
    • 超级市场/大卖场
    • 药局
    • 其他的

8. 全球骨骼和关节健康补充品市场(按最终用户划分)

  • 介绍
  • 运动员和健身爱好者
  • 老年人
  • 其他的

9. 全球骨骼和关节健康补充品市场(按地区划分)

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十一章 公司简介

  • Nestle SA
  • Procter & Gamble Company
  • Amway Corp
  • BASF SE
  • Glanbia plc
  • Herbalife Nutrition Ltd.
  • Pfizer Inc.
  • Archer Daniels Midland Company
  • Abbott Laboratories
  • Now Foods

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061614517

The global bone and joint health supplements market, with a 7.34% CAGR, is anticipated to reach USD 17.194 billion in 2030 from USD 12.066 billion in 2025.

Bones provide the foundational structure and protection for the body's organs, while joints facilitate movement. Maintaining their health is critical for overall physical well-being, with calcium being a primary nutrient for bone integrity. Bone and joint health supplements are formulated to deliver essential vitamins and minerals that support bone density, enhance joint mobility, alleviate joint pain, and slow the progression of conditions like osteoarthritis. These products offer a convenient method to address nutritional gaps and support the skeletal system, particularly as natural bone density declines with age, often manifesting initially as joint discomfort. The market for these supplements is experiencing significant demand, driven by demographic shifts and evolving consumer health awareness.

Primary Market Drivers

The expansion of the bone and joint health supplements market is predominantly fueled by the global demographic transition towards an older population and a concurrent rise in consumer awareness regarding nutritional deficiencies.

The ageing global population represents the most substantial demand-side driver for this market. Older adults are disproportionately affected by conditions that degrade bone and joint health, including osteoporosis and rheumatoid arthritis. The natural ageing process leads to a decline in bone density and the wear-and-tear of joint cartilage, increasing the prevalence of fractures, pain, and reduced mobility. This demographic seeks solutions to maintain an active and independent lifestyle, creating a large and growing target market for supplement manufacturers. The focus on achieving joint comfort and ease of movement is a powerful consumer motivator, leading to a willingness to pay a premium for products that offer targeted support for these age-related concerns.

Alongside demographic pressures, a widespread increase in health consciousness is propelling market growth. Consumers are becoming more knowledgeable about the link between nutrition and long-term health, including the role that specific micronutrient deficiencies play in the development of bone and joint disorders. This awareness is driving a proactive approach to health management, where individuals are increasingly turning to dietary supplements as a preventative measure. The growth of the middle class in many regions, accompanied by rising disposable incomes, enables higher spending on wellness and preventive healthcare products. This trend is amplified by the participation of younger demographics in sports and fitness activities, who use these supplements to support joint function and recovery from physical stress, further broadening the consumer base beyond just the elderly.

Geographical Market Outlook

North America is projected to be the prominent shareholder in the global bone and joint health supplements market. The region's dominance is underpinned by a combination of a large and growing elderly population, a high prevalence of joint-related conditions such as arthritis, and a well-established consumer culture oriented toward health and wellness. High levels of awareness regarding the importance of preventative healthcare and a history of dietary supplement usage contribute to a mature and receptive market. The significant incidence of diagnosed arthritis and micronutrient deficiencies within the population creates a sustained demand for bone and joint health solutions.

The Asia Pacific region, however, is anticipated to be the fastest-growing market during the forecast period. This accelerated growth is driven by several factors, including widespread dietary deficiencies, rapidly increasing awareness of health and well-being, and a rising incidence of conditions like osteoporosis and vitamin D insufficiency. Economic development across the region is a key enabler, as rising disposable incomes allow consumers to spend more on premium health products, including specialized supplements. The large population base, combined with growing urbanization and the adoption of modern health trends, presents immense growth potential. Strategic business initiatives and marketing efforts by supplement companies within the APAC region are further catalyzing market penetration and expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY TYPE
  • Glucosamine
  • Chondroitin
  • Omega-3 Fatty Acid
  • Vitman & Mineral Supplement
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY FORMULATION
  • Capsules & Tablets
  • Powders
  • Liquids & Soft-Gel
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY DISTRIBUTION CHANNEL
  • Online
  • Offline
  • Supermarket/ Hypermarket
  • Pharmacies
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY END-USER
  • Athletes & Fitness Enthusiasts
  • Old-Age
  • Others
  • GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Glucosamine
  • 5.3. Chondroitin
  • 5.4. Omega-3 Fatty Acid
  • 5.5. Vitman & Mineral Supplement
  • 5.6. Others

6. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY FORMULATION

  • 6.1. Introduction
  • 6.2. Capsules & Tablets
  • 6.3. Powders
  • 6.4. Liquids & Soft-Gel
  • 6.5. Others

7. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY DISTRIBUTION CHANNELS

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Offline
    • 7.3.1. Supermarket/ Hypermarket
    • 7.3.2. Pharmacies
    • 7.3.3. Others

8. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Athletes & Fitness Enthusiasts
  • 8.3. Old-Age
  • 8.4. Others

9. GLOBAL BONE AND JOINT HEALTH SUPPLEMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Nestle S.A
  • 11.2. Procter & Gamble Company
  • 11.3. Amway Corp
  • 11.4. BASF SE
  • 11.5. Glanbia plc
  • 11.6. Herbalife Nutrition Ltd.
  • 11.7. Pfizer Inc.
  • 11.8. Archer Daniels Midland Company
  • 11.9. Abbott Laboratories
  • 11.10. Now Foods

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations